Abstract

BackgroundTocilizumab (TCZ) as monotherapy (Mono) is nowadays a standard treatment in rheumatoid arthritis (RA) for patients in whom methotrexate (MTX) is inappropriate1.ObjectivesTo describe factors influencing the use of TCZ in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
FRI0116 SUBCUTANEOUS TOCILIZUMAB IN MONOTHERAPY OR IN COMBINATION WITH CSDMARD IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS: OBSERVATIONAL STUDY TO DESCRIBE REAL-WORLD DRUG RETENTION RATE AT 12 MONTHS
Alain Saraux ... Thomas Barnetche
-
Alain Saraux, et. al.Alain Saraux ... Thomas Barnetche
01 Jun 2019
FRI0220 Prescription of Tocilizumab Alone or in Combination with Dmards in Rheumatoid Arthritis Patients in A Real Life Setting: The Act-Solo Study 12 Months Results
J Tebib ... J.-F Maillefert
Annals of the Rheumatic Diseases | VOL. 75
J Tebib, et. al.J Tebib ... J.-F Maillefert
01 Jun 2016
FRI0324 Which Factors Influence the Prescription of TOCILIZUMAB (TCZ) Alone or in Combination with DMARDS in Rheumatoid Arthritis Patients in A REAL Life Setting? the Act Solo Study
J.-F Maillefert ... J Antheaume
Annals of the Rheumatic Diseases | VOL. 73
J.-F Maillefert, et. al.J.-F Maillefert ... J Antheaume
01 Jun 2014
AB0040 STUDYING THE MACROPHAGE ACTIVATION AND THE INTIMA-MEDIA THICKNESS OF THE CAROTID ARTERIES IN UNTREATED PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS (PRELIMINARY DATA)
E Gerasimova ... A Orekhov
-
E Gerasimova, et. al.E Gerasimova ... A Orekhov
23 May 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler ... Stephan Blüml
Annals of the Rheumatic Diseases | VOL. -
Markus Kieler, et. al.Markus Kieler ... Stephan Blüml
10 Jul 2024
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler ... Stephan Blüml
Annals of the Rheumatic Diseases | VOL. -
Markus Kieler, et. al.Markus Kieler ... Stephan Blüml
10 Jul 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
Matthew A Brown ... Irene Van Der Horst-Bruinsma
Annals of the Rheumatic Diseases | VOL. -
Matthew A Brown, et. al.Matthew A Brown ... Irene Van Der Horst-Bruinsma
08 Jul 2024
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Yusuke Yoshimura ... Naoki Sawa
Annals of the Rheumatic Diseases | VOL. -
Yusuke Yoshimura, et. al.Yusuke Yoshimura ... Naoki Sawa
04 Jul 2024
View more papers